Dosing appears to play a role some trials have shown antioxidant effects with 800mg/day, while others suggest stronger responses at 1,2002,400mg/day, particularly for lowering oxidative stress biomarkers in patients with multiple sclerosis.3 28 Keep in mind, though: while higher doses (typically 1,2002,400mg per day) may offer stronger antioxidant effects, they also come with a greater chance of side effects like upset stomach or dizziness
Iron-dependent enzymes known to drive ferroptosis include lipoxygenases (LOX), cyclooxygenases (COX), and cytochrome P450 oxidoreductases (POR) [53,54,55,56], all of which catalyse the formation of bioactive LOOH, which regulates cellular signalling
Conclusions and perspectives Despite all the controversy in this space, the general consensus is that irAEs are not a pre-requisite for ICI benefit but rather a positive heralding sign of clinical benefit
Provider Disclaimer IGF-1 LR3 is research-grade and not FDA-approved for human use